DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate.
D000256:Adenoviridae / Q000187:drug effects; D000818:Animals; D002294:Carcinoma, Squamous Cell; D002478:Cells, Cultured; D003500:Cyclization; D003561:Cytarabine / Q000494:pharmacology*; D003587:Cytomegalovirus / Q000187:drug effects; D003597:Cytosine Nucleotides / Q000494:pharmacology*; D004267:DNA Viruses / Q000187:drug effects*; D006564:Herpesviridae / Q000187:drug effects; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009233:Myxoma virus / Q000187:drug effects; D009303:Nasopharyngeal Neoplasms; D010710:Phosphates; D011557:Pseudorabies / Q000382:microbiology; D011817:Rabbits; D014615:Vaccinia / Q000188:drug therapy; D014616:Vaccinia virus / Q000187:drug effects
D003597:Cytosine Nucleotides; D010710:Phosphates; D003561:Cytarabine